VHL and neoplasm: Genetic studies, next-generation sequencing data and transgenic mouse models illustrate the central role of the von Hippel–Lindau (VHL) tumor suppressor and the downstream hypoxia pathway in ccRCC pathogenesis [6,7,8,9].